该研究由生产艾可拓的武田制药赞助。
The study was funded by Takeda Pharmaceuticals, which manufactures Actos.
它的部分经费由吡格列酮的制造商武田制药提供。
It was financed in part by Takeda Pharmaceuticals, maker of pioglitazone.
该项研究在周四发表于《新英格兰医学杂志》。它的部分经费由吡格列酮的制造商武田制药提供。
The study was published on Thursday in The New England Journal of Medicine. It was financed in part by Takeda Pharmaceuticals, maker of pioglitazone.
应用推荐